AIM2 Protein Drives Gum Cell Aging and Fuels Chronic Inflammation in Periodontitis
A new study reveals how AIM2 locks gingival fibroblasts into a senescent, pro-inflammatory state, worsening periodontal tissue destruction.
Résumé
Researchers discovered that the innate immune sensor AIM2 is significantly elevated in periodontitis-affected gum tissue, where it drives gingival fibroblasts into cellular senescence rather than apoptosis. This senescent state amplifies the secretion of inflammatory mediators — a phenomenon known as inflammaging. AIM2 levels correlated directly with clinical markers of gum disease severity, including bleeding and attachment loss. In lab experiments, overexpressing AIM2 in human gingival fibroblasts increased oxidative stress and p16INK4A senescence markers while reducing cell death, producing a pro-survival, pro-inflammatory phenotype. RNA sequencing identified broad transcriptional changes in inflammation, p53, and DNA damage pathways, plus widespread alternative splicing. The findings position AIM2 as a potential therapeutic target to break the self-reinforcing cycle of chronic inflammation and cellular aging in periodontal disease.
Résumé détaillé
Periodontitis is among the most prevalent chronic inflammatory diseases globally, and its connection to systemic aging and inflammaging is increasingly recognized. This study investigates a specific molecular driver — the innate immune DNA sensor AIM2 — that may link local gum infection to accelerated cellular senescence and sustained tissue-damaging inflammation.
Researchers examined gingival tissue from periodontitis patients and healthy controls using multiplex immunofluorescence, measuring AIM2 alongside DNA damage marker γH2AX, senescence marker p16INK4A, and inflammatory mediators including IL-6, IL-1β, caspase-1, ASC, and GSDMD. AIM2 was upregulated 2.7-fold in the epithelium and 2.4-fold in the lamina propria of periodontitis tissue, with co-localization of AIM2, γH2AX, and p16INK4A confirming senescent fibroblasts as key players. AIM2 levels positively correlated with clinical measures of disease severity.
In human gingival fibroblasts (hGFs), AIM2 overexpression increased p16INK4A expression and reactive oxygen species while suppressing apoptosis — effectively steering cells toward a senescence-survival phenotype with enhanced senescence-associated secretory phenotype (SASP). Conversely, siRNA knockdown of AIM2 reversed these effects. RNA-seq analysis revealed enrichment of inflammatory, ribosome/spliceosome, and p53-related pathways, along with extensive alternative splicing in genes governing lipid metabolism, innate immunity, and DNA damage responses.
These findings establish AIM2 as a regulatory hub that integrates DNA damage sensing with senescence signaling, creating a positive feedback loop between chronic inflammation and cellular aging in periodontal tissue. Importantly, this mechanism may contribute to broader age-related inflammatory deterioration beyond the mouth.
Caveats include the study's reliance on in vitro models and cross-sectional tissue samples, with no in vivo animal validation or clinical intervention data reported. Causality in human disease remains to be confirmed in longitudinal studies.
Principales conclusions
- AIM2 expression rose 2.7-fold in gingival epithelium and 2.4-fold in lamina propria in periodontitis patients.
- AIM2 levels correlated positively with bleeding on probing and clinical attachment loss.
- AIM2 overexpression pushed gingival fibroblasts into senescence, raising ROS and p16INK4A while reducing apoptosis.
- RNA-seq revealed AIM2-driven enrichment of p53, inflammatory, and spliceosome pathways plus widespread alternative splicing.
- AIM2 creates a self-reinforcing inflammaging loop and is proposed as a therapeutic target for periodontal disease.
Méthodologie
The study used multiplex immunofluorescence on human gingival biopsy samples from periodontitis patients and healthy controls to map AIM2, senescence, and inflammatory markers in situ. Human gingival fibroblasts were engineered for AIM2 overexpression or siRNA knockdown, followed by SASP profiling and RNA sequencing to assess transcriptional and alternative splicing changes. This is a cross-sectional human tissue study combined with cell-based mechanistic experiments; no animal models were employed.
Limites de l'étude
The study lacks in vivo animal model validation, limiting mechanistic conclusions in a living organism context. Cross-sectional tissue sampling prevents causal inference about whether AIM2 elevation precedes or results from periodontitis progression. Therapeutic strategies targeting AIM2 remain speculative and require drug development and clinical testing before any patient application.
Ce résumé vous a plu ?
Recevez les dernières recherches sur la longévité dans votre boîte de réception chaque semaine.
Saisissez votre e-mail pour vous abonner :